Tactile Systems Technology Inc 뉴스 - TCMD | 주식 나스닥 | ADVFN

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Tactile Systems Technology Inc (TCMD)
Tactile Systems Technology Inc (TCMD) 뉴스

Tactile Systems Technology Inc (TCMD)

17.51

-0.45

(-2.51%)

마감 01 2월 6:00AM

17.2147

-0.2953

(-1.69%)

시간외 거래: 9:58AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Tactile Medical Appoints Laura King to Board of Directors

MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:...

Tactile Medical to Present at the Piper Sandler 36th Annual Healthcare Conference

MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial Results

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024

MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

UPDATE -- Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

Tactile Medical Receives PDAC Approval for Nimbl™ Lymphedema Platform

MINNEAPOLIS, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

KeepOn

KeepOn 3 년 전

Not holding here, yet. Just on watch.

KeepOn

KeepOn 3 년 전

Trying to bottom out, here.

AugustStockInformer

AugustStockInformer 8 년 전

Great interview with Tactile Medical CEO to kick off this board.

https://www.twst.com/interview/interview-with-the-ceo-and-director-tactile

TWST: Help us understand a little bit more about the product and what it is designed to do.

Mr. Mattys: Flexitouch was actually designed by a lymphedema therapist to try to mimic the manual therapy that she was applying in the clinic. The patient can use it at home. It is emulating, through mechanized gentle massage, the therapy that lymphedema therapists apply to these patients to try to get fluid moving from a swollen extremity.

The Flexitouch System is a device that patients can put on and take off by themselves at home for treatment for one hour each day. He or she puts on the garment, pushes the activation button on the device, and then sits back and relaxes while it applies what feels like a nice sports massage to the swollen area.

TWST: Is it appropriate for all lymphedema patients? And then, after you answer that, can you tell us how many lymphedema patients there might be in the United States?

Tactile Systems Technology

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관